Biotech China 2014
5th annual BioPharma Asia Convention 2012


Singapore, Singapore
http://www.terrapinn.com/exhibition/biopharma-asia
Keywords: BioPharma Asia Convention

Schedule of Presentations:

Monday, March 19, 2012
09:15:00 Keynote: The role of Asia in preclinical development of pharmaceuticals Thomas Singer
09:15:00 Panel Session: The rise of Asian CMOs in the global pharmaceutical industry
09:15:00 Panel Session: The rise of Asian CMOs in the global pharmaceutical industry
09:15:00 Panel Session: The rise of Asian CMOs in the global pharmaceutical industry Uwe Bucheler
09:45:00 Developing a suitable business model for your preclinical drug development in Asia Helen Han
10:50:00 Panel Discussion: Assessing Asia’s competitiveness and growth opportunities in conducting preclinical trials Michael DuVall
11:15:00 Developing an innovative preclinical model to drive R&D productivity Haiyan Jiang
11:45:00 Effectively managing preclinical studies input from global sites for your preclinical pipeline Wouter Schul
12:15:00 Panel Discussion: Optimizing your partnership collaboration for outsourcing preclinical studies in Asia Vivek J. Kadambi
12:15:00 Panel Discussion: Optimizing your partnership collaboration for outsourcing preclinical studies in Asia E. Stewart Geary
Tuesday, March 20, 2012
09:00:00 Keynote Plenary Session: Future Pharma – Transformation, Business Models & Innovation Chihiro Yokota
09:00:00 Keynote Plenary Session: Future Pharma – Transformation, Business Models & Innovation
09:00:00 Keynote Plenary Session: Future Pharma – Transformation, Business Models & Innovation
09:00:00 Keynote Plenary Session: Future Pharma – Transformation, Business Models & Innovation Andrea Busch
11:15:00 Chairman’s opening remarks Michael Kleine
11:20:00 Keynote: Strategic Alliances: Building Blocks to Growth in Asia
11:20:00 Panel Discussion: Growth opportunities for biologics manufacturing industry in Asia: Will Asia complement or replace their western counterparts? Wei-Kuang Chi
11:20:00 Panel Discussion: Growth opportunities for biologics manufacturing industry in Asia: Will Asia complement or replace their western counterparts?
11:20:00 Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines Paul Bolno
11:20:00 Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines Helmut Haning
11:20:00 Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines
11:20:00 Pharma Manufacturing World Esther Alegria
11:35:00 Exploring innovative business models and development strategies to meet evolving R&D challenges
11:50:00 Managing risk for temperature controlled transportation
11:50:00 Manufacturing excellence: Sustaining momentum of a lean transformation
11:50:00 Utilising emerging technologies to develop commercially scalable manufacturing platforms for biotherapeutic production Svend Licht
11:55:00 Medicinal chemistry outsourcing in Asia: Lessons learned
12:00:00 Forging open partnerships between Pharmas and Biotechs to foster increased innovation in Asian clinical development
12:10:00 Leveraging on Asian biotechs as a means of ensuring continuous growth of global pharmas Kiran Mazumdar
12:10:00 Cost reduction by design strategies for efficient manufacturing operations Sampad Bhattacharya
12:20:00 Exploring cost effective logistic strategies in emerging markets
14:00:00 Delivering enhanced customer value: A collaboration-centric R&D model
14:00:00 Panel: Comparing business development strategies in Asia
14:00:00 Optimising operational processes and eradication of defects due to human interaction through DDFP
14:00:00 Panel: Comparing business development strategies in Asia
14:00:00 Leveraging on integrated innovative technology to increase trial design efficiency Graham Bunn
14:00:00 Panel: Comparing business development strategies in Asia Anand Gautam
14:00:00 Creating the best products: Aligning your supply chain process with quality compliance
14:20:00 Formulating lead validation strategies to explore the key factor for future success in target validation: An NMR based approach
14:20:00 Evolution of comparability for biologics: Uncovering important scientific and regulatory considerations Wassim Nashabeh
14:20:00 Optimizing fermentation control with optical cell growth sensors
14:30:00 Critical issues in protecting and maximizing IP value in a dynamic market environment Peter Homberg
14:40:00 Developing biosimilars for success –Hanwha’s Bio Business Unit’s experience
14:40:00 Increasing protocol compliance during clinical trials through effective use of technology
14:40:00 Strategies and developments in next generation small molecule therapeutics Hans Joachim Boehm
14:40:00 IT tool for quality risk management Flemming Simonsen
14:50:00 Pharma Partnering & Investment World Asia
15:00:00 Sponsor’s perspective: Utilizing clinical technology to accelerate your trial progress
16:00:00 Formulating innovative and effective therapeutic treatments for neurodegenerative diseases Ceri Davies
16:15:00 Analytical method development strategy for cell line selection and process development
16:15:00 Emerging South-East Asia: Capitalizing on the heterogeneity of different markets to achieve clinical trial excellence Kenneth S. Lee
16:15:00 Leveraging on partnerships in accessing the markets of China
16:15:00 Leveraging on partnerships in accessing the markets of China
16:15:00 Enhancing LSP-client relationships to optimise supply chain performance in Asia
16:20:00 Encapsulated porcine islet transplants for treatment of diabetes Bob Elliott
16:35:00 Enhancing yield and quality of biotherapeutics via host cell engineering Christian H. Leist
16:40:00 Exploiting immune system specificity to develop soluble molecules that target HBV infected hepatocytes Adam J. Gehring
16:45:00 Panel: Determining your business strategy in Asia: Not one size fits all – Customising solutions for different needs
16:45:00 Panel: Determining your business strategy in Asia: Not one size fits all – Customising solutions for different needs
16:45:00 Panel: Determining your business strategy in Asia: Not one size fits all – Customising solutions for different needs
16:45:00 Analysing the business partnership models of mid - sized pharmas with Asian counterparts
16:45:00 Panel: Determining your business strategy in Asia: Not one size fits all – Customising solutions for different needs Larry Ajuwon
16:45:00 Analysing the business partnership models of mid - sized pharmas with Asian counterparts
16:45:00 Analysing the business partnership models of mid - sized pharmas with Asian counterparts
17:05:00 Alternative partnering models for lifescience ventures
Wednesday, March 21, 2012
08:50:00 Chairman’s opening remarks Uwe Gottschalk
09:00:00 Managing the needs of vaccine manufacturing in Asia for improved manufacturing operations
09:00:00 Success strategies in identifying and evaluating investment prospects in Asia
09:00:00 Optimising your clinical supply chain with complex distribution by utilizing Monte Carlo simulations Kunal Jaiswal
09:00:00 Regulatory panel: Overcoming regulatory barriers in Asia to fast-track clinical trials Young-ok Kim
09:00:00 Success strategies in identifying and evaluating investment prospects in Asia John Diekman
09:00:00 Success strategies in identifying and evaluating investment prospects in Asia
09:00:00 Regulatory panel: Overcoming regulatory barriers in Asia to fast-track clinical trials
09:00:00 Regulatory panel: Overcoming regulatory barriers in Asia to fast-track clinical trials
09:15:00 Insights into next generation drug discovery in Singapore
09:20:00 Leveraging on manufacturing compliance and quality to capture profit growths
09:30:00 Panel Discussion: Overcoming business risks and uncertainties in a dynamic global supply chain network
09:30:00 Panel Discussion: Overcoming business risks and uncertainties in a dynamic global supply chain network
09:30:00 Panel Discussion: Overcoming business risks and uncertainties in a dynamic global supply chain network
09:35:00 An R&D strategy to achieving “proof of value”
09:40:00 Commercial preparation of acellullar pertussis vaccine through effective recovery and purification using tangential flow filtration Rakesh Kumar
09:40:00 Navigating the complex field of GMP and regulatory compliance of the API industry
09:50:00 Aligning with the various regulatory requirements in Asia for successful clinical trial submissions
09:55:00 Lead discovery strategy at Institut Pasteur Korea
11:05:00 High throughput quantitative analysis of new chemical entities in biological fluids: can we achieve a 10 seconds analysis time per sample? Olivier Heudi
11:15:00 Panel: Exploiting the favourable clinical trial environment in East Asia
11:15:00 Panel: Exploiting the favourable clinical trial environment in East Asia
11:15:00 Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation Propensity Bernhard Helk
11:35:00 Employing technology transfer for optimal operational processes
11:45:00 Utilizing passive thermal packaging technology to actively reduce risk Joachim Kuhn
11:55:00 Recognising challenges in scale-up of proteins produced from microbial fermentation
11:55:00 Going beyond borders to build value in Asian healthcare investments
14:00:00 Translation of government led incentives into the lifescience industry and economic growth Mohd Nazlee Kamal
14:00:00 Applying lean to the overall value chain of a continuous process organisation
14:00:00 Discovering modern personalized medicine with innovative biomarkers Iman El-Hariry
14:20:00 Translation imaging for CNS drug discovery and development
14:20:00 Planning your studies in South East Asia: Importance of understanding the local regulatory systems
14:20:00 Presenting proof of concept to access government and alternative funding Carrie Hillyard
14:20:00 Enhancing process efficiency through process integration Tatsuya Takano
14:20:00 Increasing throughput through collaboration and capacity management
15:00:00 Panel: Mapping out the challenges and opportunities for clinical trials in South East Asia
15:00:00 Panel: Mapping out the challenges and opportunities for clinical trials in South East Asia
16:00:00 The current status of the first-in-class dual inhibitor of PI3K and Erk AEZS-132 Martin Everett
16:15:00 Panel: Optimising clinical trials in Asian powerhouses – India & China
16:15:00 Panel: Optimising clinical trials in Asian powerhouses – India & China
16:15:00 Enhancing contract manufacturing operations in Asia with single-use systems
16:15:00 Recognizing the criteria that VCs look for when investing in small startup companies Goro Takeda
16:15:00 Panel: Optimising clinical trials in Asian powerhouses – India & China
16:20:00 Deduction of novel phenotypes and disease mechanisms in uropathogenic E.coli using comparative evolutionary analysis
16:35:00 Optimising your biologic manufacturing operations through single-use technologies application
16:40:00 Accelerating drug discovery with fluorescent-tagged antimalarials Kevin Tan
Thursday, March 22, 2012
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.